Role of Nanoformulations in the Treatment of Lung Cancer
Parijat Pandey,Gunjan Nautiyal,Deepika Purohit,Sneh Lata,Virender Kumar,Manish Makhija,Deeksha Manchanda,Neha Minocha,Sunil Kumar,Deepak Kaushik,Sneh lata
DOI: https://doi.org/10.2174/0118722105264531231205042817
2024-02-06
Recent Patents on Nanotechnology
Abstract:Abstract: Lung cancer is the second deadliest disease in the world. A major portion of deaths related to cancer are due to lung cancer in both males and females. Interestingly, unbelievable advances have occurred in recent years through the use of nanotechnology and development in both the diagnosis and treatment of lung cancer. Due to their in vivo stability, the nanotechnology-based pharmacological system gained huge attractiveness, solubility, absorption from the intestine, pharmacological effectiveness, etc. of various anticancer agents. However, this field needs to be utilized more to get maximum results in the treatment of lung cancer, along with wider context medicines. In the present review, authors have tried to concentrate their attention on lung cancer`s difficulties along with the current pharmacological and diagnostic situation, and current advancements in approaches based on nanotechnology for the treatment and diagnosis of lung cancer. While nanotechnology offers these promising avenues for lung cancer diagnosis and treatment, it is important to acknowledge the need for careful evaluation of safety, efficacy, and regulatory approval. With continued research and development, nanotechnology holds tremendous potential to revolutionize the management of lung cancer and improve patient outcomes. The review also highlights the involvement of endocrine systems, especially estrogen in lung cancer proliferation. Some of the recent clinical trials and patents on nanoparticle-based formulations that have applications in the treatment and diagnosis of lung cancer are also discussed.
materials science, multidisciplinary,physics, applied,nanoscience & nanotechnology